Robotic-Assisted Navigation for Lung Nodule Localization: A Non-Inferiority Study
The Effectiveness of Robotic-assisted Navigation System for Preoperative Lung Nodule Localization: a Prospective, Single-center, Non-inferiority Clinical Study
1 other identifier
interventional
100
1 country
1
Brief Summary
This study compares robotic-assisted navigation and manual CT-guided needle localization for lung nodules under 20 mm. It aims to evaluate localization success, procedure duration, CT scans, and complication rates.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedFirst Submitted
Initial submission to the registry
June 29, 2025
CompletedFirst Posted
Study publicly available on registry
July 9, 2025
CompletedJuly 9, 2025
June 1, 2025
7 months
June 29, 2025
June 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Localization Success Rate
The accuracy of nodule localization was designated as the primary outcome of the study. Successful localization was defined as a distance of less than 10 mm between the needle tip and the center of the nodule, with no displacement of the localization device between localization and surgery.
Immediately after needle localization and before surgery
Secondary Outcomes (5)
Procedure Duration
From patient positioning on the CT scanner to confirmation of successful needle insertion via final CT scan
Number of CT Scans Required for Localization
During the localization procedure
Total Dose-Length Product (DLP)
During the localization procedure
First-pass Success Rate
Immediately after the first needle insertion
Localization Success Rate within One Needle Adjustment
Immediately after one needle adjustment
Study Arms (2)
Freehand group
ACTIVE COMPARATORManual CT-guided percutaneous needle localization of pulmonary nodules
Robotic group
EXPERIMENTALRobotic-assisted CT-guided percutaneous needle localization of pulmonary nodules
Interventions
Robot-assisted needle localization involves the use of a robotic system to assist with the percutaneous localization of pulmonary nodules under CT guidance. The robotic system provides real-time navigation and increased precision during needle placement, reducing the variability in positioning and improving the accuracy of localization. The system offers automatic adjustments to the needle's trajectory, minimizing the need for manual corrections, and potentially reducing the number of CT scans required. This method is designed to enhance the overall localization success rate and reduce complications associated with traditional manual techniques.
Manual needle localization involves the traditional technique of percutaneous localization of pulmonary nodules under CT guidance without the assistance of robotic systems. The procedure is performed by the physician manually guiding the needle based on real-time CT imaging. The physician adjusts the needle position based on visual cues from the CT scan, which may require multiple attempts for accurate localization.
Eligibility Criteria
You may qualify if:
- (Ⅰ) isolated pulmonary nodules with a maximum diameter of less than 20 mm; (Ⅱ) the presence of pure ground-glass opacity (GGO) or mixed GGO (solid to tumor ratio \< 0.5) on CT with clinical or radiological suspicion of malignancy; (Ⅲ) patient with a peripheral nodule, located in the outer third of the lung parenchyma, with its edge situated at least 5 mm away from the pleural surface; (Ⅳ) Eastern Cooperative Oncology Group performance status (ECOG PS) score of 0-1, indicating suitability for surgical intervention.
You may not qualify if:
- (Ⅰ) nodule location obstructed by the scapula, precluding needle access; (Ⅱ) proximity of the nodule to major blood vessels, defined as within 2 cm; (Ⅲ) requirement for localization of multiple pulmonary nodules.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The First Affiliated of Guangzhou Medical University
Guangzhou, Guangdong, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 29, 2025
First Posted
July 9, 2025
Study Start
June 1, 2024
Primary Completion
December 31, 2024
Study Completion
March 1, 2025
Last Updated
July 9, 2025
Record last verified: 2025-06